Xolar® (Holair®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceOmalizumabOmalizumab
Similar drugsTo uncover
  • Xolar
    lyophilizate PC 
    Novartis Pharma AG     Switzerland
  • Xolar®
    solution PC 
    Novartis Pharma AG     Switzerland
    • Dosage form: & nbsphypodermic solution
    ATX: & nbsp

    R.03.D.X.05   Omalizumab

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004376
    Date of registration:17.07.2017
    Expiration Date:17.07.2022
    The owner of the registration certificate:Novartis Pharma AGNovartis Pharma AG Switzerland
    Manufacturer: & nbsp
    Illustrated instructions
      Instructions
      Up